Rosuvastatin calcium
- Level
- Commodity
- Parent
- 51322200
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51322205This classification denotes a hmg-coa reductase inhibitor with the molecular formula 2C22H27FN3O6S.CA, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 83MVU38M7Q. European Medicines Agency schedules rosuvastatin calcium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB20721. The term rosuvastatin calcium is a United States Adopted Name designation. Most nations, for tariff and trade purposes, schedule rosuvastatin calcium under HS 29350090 and SITC 51580. As of Q4 2014, ROSUVASTATIN CALCIUM remains US FDA's Preferred Term for this commodity. Rosuvastatin calcium bears US NLM identifiers UMLS ID C1101751 and NCI Concept Code C61933. SMILES: CC(C1NC(NC(C1/C=C/[C@@H](O)C[C@@H](O)CC(=O)[O-])C2CCC(CC2)F)N(S(=O)(=O)C)C)C.CC(C1NC(NC(C1/C=C/[C@@H](O)C[C@@H](O)CC(=O)[O-])C2CCC(CC2)F)N(S(=O)(=O)C)C)C.[CA+2].
Same parent
Under 51322200 · 6Activities that produce or sell this
KBLI · 8Inherited from family 51320000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.